Our Media & Newsroom serves as a vital resource, offering insights and updates that keep our community informed. Explore key developments, important announcements, and resources that elevate our mission.
Welcome to the official media hub of the DSHEA Preservation Alliance. Here, journalists, researchers, and stakeholders can access reliable information, timely updates, and expert perspectives on the policies, challenges, and successes shaping the future of dietary supplement regulation. Whether you’re covering legal developments, tracking FDA activity, or exploring DSHEA’s impact on public health and innovation, our newsroom offers curated resources to support your work. Browse our press releases, statements, and recent headlines—or reach out directly for customized support. We’re here to ensure clarity, credibility, and context in every story.
On July 21, 2025, the Orrin G. Hatch Foundation hosted a timely and important conversation on the future of the Dietary Supplement Health and Education
By Matt SandgrenMatt is the executive director of the Orrin G. Hatch Foundation. A 15-year veteran of Capitol Hill, he served as senior counsel on the Senate
The Wall Street Journal reported on the booming longevity industry and the regulatory challenges faced by companies marketing NMN supplements. The article highlights the dispute
A federal court mandated the FDA to halt enforcement actions against NMN vendors and required the agency to address the NPA’s pending citizen petition. This decision
The NPA hailed the court’s decision to stay the NMN lawsuit as a “monumental victory,” emphasizing that the FDA exceeded its authority and must adhere
A federal court granted a joint motion filed by the NPA and FDA to stay proceedings in the NMN lawsuit, pending the FDA’s response to
The Natural Products Association (NPA) filed a lawsuit challenging the FDA’s determination that NMN is excluded from the definition of a dietary supplement due to its prior investigation as a drug. The NPA argues that the FDA’s retroactive application of the law is unlawful and harms the dietary supplement industry.
...The FDA announced that β-nicotinamide mononucleotide (β-NMN) is not a legal dietary ingredient, citing its prior investigation as a drug. The Council for Responsible Nutrition (CRN) responded, expressing concern that this decision stifles innovation and disregards consumer interests.
...For all media requests or press inquiries related to the DSHEA or the DSHEA Preservation Alliance, please get in touch with us at [email protected]. We’re happy to assist journalists, researchers, and media professionals with timely information, expert insights, and background materials.
Subscribe to receive the latest updates on DSHEA enforcement, regulatory developments, research insights, and advocacy efforts—curated for policymakers, health professionals, industry leaders, and researchers.
